Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL
作者： Christina Voelkel-Johnson , Deanne Lea King , James Scott Norris , None
关键词:
摘要: Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery full-length TRAIL
nature.com
paperity.org参考文章(35)
Erica O’Bryan, Ramadevi Nimmanapalli, Marianagelli Orlando, Charles L. Perkins, Diep Nguyen, Kapil N. Bhalla, Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Research. ,vol. 61, pp. 759- 763 ,(2001)
Peter Hersey, Xu Dong Zhang, Tam Nguyen, Relative Resistance of Fresh Isolates of Melanoma to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis Clinical Cancer Research. ,vol. 7, ,(2001)
Jinghai Wen, Nimmanapalli Ramadevi, Diep Nguyen, Charles Perkins, Elizabeth Worthington, Kapil Bhalla, Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells Blood. ,vol. 96, pp. 3900- 3906 ,(2000) , 10.1182/BLOOD.V96.12.3900
Gen Sheng Wu, Kunghong Kim, Wafik S. El-Deiry, KILLER/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death. Advances in Experimental Medicine and Biology. ,vol. 465, pp. 143- 151 ,(2002) , 10.1007/0-306-46817-4_13
Heiko Stahl, Peter H. Krammer, Axel Bouchon, Henning Walczak, Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Cancer Research. ,vol. 60, pp. 3051- 3057 ,(2000)
Sandhya Mandlekar, Steve Ruben, A-N. Tony Kong, Rong Yu, Jian Ni, Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells. Cancer Research. ,vol. 60, pp. 2384- 2389 ,(2000)
M. Nagane, H.-J. S. Huang, W. K. Cavenee, The potential of TRAIL for cancer chemotherapy. Apoptosis. ,vol. 6, pp. 191- 197 ,(2001) , 10.1023/A:1011336726649
Minji Jo, Tae-Hyoung Kim, Dai-Wu Seol, James E. Esplen, Kenneth Dorko, Timothy R. Billiar, Stephen C. Strom, Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand Nature Medicine. ,vol. 6, pp. 564- 567 ,(2000) , 10.1038/75045
Marie-Thérèse Dimanche-Boitrel, Anne Wotawa, Arlette Hammann, Sandrine Lacour, Laurent Corcos, Eric Solary, Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. Cancer Research. ,vol. 61, pp. 1645- 1651 ,(2001)
J. Norris, M. Hyer, C. Voelkel-Johnson, S. Lowe, S. Rubinchik, J-Y. Dong, The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer. Current Gene Therapy. ,vol. 1, pp. 123- 136 ,(2001) , 10.2174/1566523013348977